Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2003
06/25/2003CN1425462A Changqing tablet and its preparing method
06/25/2003CN1425456A Nourishing wine for regulating human body balance function
06/25/2003CN1425453A Medicine for curing diseases of gastrointestinal system
06/25/2003CN1425452A Longan aril and wolfberry fruit polysaccharide health-care liquid and its preparing method and use
06/25/2003CN1425447A Traditional Chinese medicine composition for curing child's dyspepsia and cough and its preparing method
06/25/2003CN1425445A Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid
06/25/2003CN1425440A Traditional Chinese medicine for curing functional indigestion and its preparing process
06/25/2003CN1425428A Process for preparing Liuwei aucklandia root tablet
06/25/2003CN1425424A Specific remedy for curing duodenal and gastric ulcer
06/25/2003CN1425420A Medicine for curing fat liver of obesity and its preparing method
06/25/2003CN1425417A Medicine for dispelling heat of liver and toxin to treat hepatitis B
06/25/2003CN1425404A Nourishing medicinal wine
06/25/2003CN1425400A Health preserving tea
06/25/2003CN1425384A Use of total polygalin in preparing medicine for promoting gastrointestinal peristalsis
06/25/2003CN1425383A Product of ginsenoside for curing hepatitis
06/25/2003CN1425373A Slow-releasing kurarinol preparation and its preparing method
06/25/2003CN1112211C Medicine for treating lithiasis
06/25/2003CN1112210C Chinese medicine preparation for invigorating kidney and activating blood circulation and its preparing process and application
06/25/2003CN1112201C Chinese medicine for curing hepatitis B
06/25/2003CN1112197C Chinese medicine preparation for treating precancerous lesion of atrophic gastritis
06/25/2003CN1112194C Compound yexiazhu medicine and preparing process thereof
06/25/2003CN1112193C Chinese medicine for treating hepatitis B and hepatic fibrosis and its preparing process
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583145 Thio-oxindole derivatives
06/24/2003US6583143 CRF receptor antagonists and methods relating thereto
06/24/2003US6583137 Protease inhibitors
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6583128 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
06/24/2003US6583127 Administering phosphatides such as 1-O-octadecyl-2-O-methyl glycero-3-phosphocholine, enantiomers and/or stereisomers as antiinflammatory agents for prophylaxis of inflammatory bowel disease, gastrointestinal or respiratory system disorders
06/24/2003US6583126 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582747 Dry cocoa mix containing a mixture of non-alkalized and alkalized cocoa solids
06/24/2003US6582717 Drug delivery composition and device
06/24/2003US6582688 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds
06/24/2003US6582351 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/21/2003CA2414905A1 N-(cyclopropylmethyl)azacycloalkanes, compositions containing them and methods of preparation
06/19/2003WO2003050190A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof
06/19/2003WO2003050129A1 Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003050123A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists
06/19/2003WO2003050121A1 Thioether substituted imidazoquinolines
06/19/2003WO2003050119A2 Urea substituted imidazopyridines
06/19/2003WO2003050118A1 Amide substituted imidazopyridines
06/19/2003WO2003050117A1 Sulfonamido substituted imidazopyridines
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050095A1 Substituted benzoxazoles and analogues as estrogenic agents
06/19/2003WO2003050090A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003WO2003050067A2 Vitamin d analogues
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003050053A2 Use of an antimicrobial glass ceramic for dental care and oral hygiene
06/19/2003WO2003049804A2 Treatment of genitourinary tract disorders
06/19/2003WO2003049774A1 Transdermal transport of compounds
06/19/2003WO2003049760A1 Compositions and method for treating hepatitis virus infection
06/19/2003WO2003049752A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
06/19/2003WO2003049749A1 Treatment of dairy cattle through use of electrochemically activated, aqueous solutions
06/19/2003WO2003049742A1 Method for administering birb 796 bs
06/19/2003WO2003049738A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
06/19/2003WO2003049730A1 Treatment of statin side effects using uridine derivatives
06/19/2003WO2003049723A2 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003WO2003049721A1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
06/19/2003WO2003049718A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003005960A3 Novel bicyclic and tricyclic cannabinoids
06/19/2003WO2003004096A3 Method and composition for prolonging the residence time of drugs in the gut
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114668 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
06/19/2003US20030114554 Comprising filler, polymerizable resin, polymeric handling modifier dispersed in polymerizable resin at 25 degrees C and having molecular weight of 500-100,000, initiator
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114478 Asthma therapy; antiinflammatory agents
06/19/2003US20030114468 Psychological disorders
06/19/2003US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders
06/19/2003US20030114456 Antiinflammatory agents, analgesics, antipyretics
06/19/2003US20030114455 Sexual disorders
06/19/2003US20030114453 Antiinflammatory agents; asthma; skin disorders
06/19/2003US20030114449 Saccharin derivatives as orally active elastase inhibitors
06/19/2003US20030114439 Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
06/19/2003US20030114418 Analgesics; antiinflammatory and arthritic agents; osteoarthritis; rheumatic diseases; gastrointestinal, nervous system, respiratory disorders; wound healing agents; vision defects; kits
06/19/2003US20030114416 Analgesics; antiinflammatory, -arthritic agents; vision defects; gastrointestinal and uorgenital disorders; wound healing agents; kits
06/19/2003US20030114364 Administering lactoferrin and glycomacropeptide; microbiocides
06/19/2003US20030113867 Muscle receptor proteins; transport proteins; antitumor agents; antiinflammatory agents; antidiabetic agents; modulation of muscle contraction
06/19/2003US20030113840 25 human secreted proteins
06/19/2003US20030113789 Protease peptides; anticarcinogenic agents; neurotransmitters; antidiabetic agents
06/19/2003US20030113418 Dry product of defatted whole egg of eggs of a fowl bred by feeding a feed having blended therein dry product of Angelica keiskei, a dry product of brown algae, and optionally a dry product of Theaceae Camellia.
06/19/2003US20030113393 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
06/19/2003US20030113376 Omeprazole formulation
06/19/2003US20030113375 Pharmaceutical formulation and process
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113338 Immunogenic detoxified mutant e. coli lt-a toxin
06/19/2003US20030113321 Novel G-protein-coupled receptor protein and its DNA
1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 1258